Healthcare
Live Price
Offline$6.93
+2.51% today
1Y Change
+17.16%
Window
Jun 23, 2025 โ Jun 17, 2026
Coverage: 248 bars ยท Jun 23, 2025 โ Jun 17, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Silence Therapeutics plc (SLN) is a Healthcare stock with a market cap of $340.00M and listed on NASDAQ. The stock last traded around $6.93 and up 17.2% across the available one-year price window (Jun 23, 2025 โ Jun 17, 2026). Baseline metrics include revenue growth of -98.7%, EPS growth of +20.3%, a dividend yield of 0.0%. What stands out right now is revenue -98.7%, EPS +20.3%, free cash flow +8.1% with operating margin -16292.8% and ROIC -77.3%. Valuation already assumes a fairly strong business story at price/sales 602.5. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines SLN price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
SLN
โ
Normalized return
SPY
โ
S&P 500
Excess Return
โ
Relative to SPY
SLN Max Drawdown
-41.89%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Uses the longest available daily history for SLN and SPY.
Next Step
Earnings pages get much more useful when they are tied back to upcoming dates, expectations, and peer setups.